Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSBR | ITRM | TARA | ||
| Company | Champions Oncolog | Iterum Therapeutics Plc | Artara Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.61 | 2.30 | 2.96 | ||
| High | 4.61 | 2.42 | 3.63 | ||
| Low | 4.11 | 2.20 | 2.79 | ||
| Last | 4.30 | 2.39 | 3.54 | ||
| Change | -0.02 | +0.15 | +0.72 | ||
| % Change | -0.46% | +6.70% | +25.53% | ||
| Volume | 10,900 | 786,700 | 1,157,400 | ||
| 20-Day Average Volume | 9,660 | 1,186,380 | 232,525 | ||
| Previous Close | 4.32 | 2.24 | 2.82 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.41 | 1.71 | 2.63 | ||
| 20-Day Raw Stochastic | 36.69% | 90.08% | 93.66% | ||
| 20-Day Relative Strength | 48.31% | 71.47% | 69.33% | ||
| Weighted Alpha | -17.62 | +8.01 | +74.37 | ||
| Today's Opinion | 88% Sell | 88% Buy | 40% Buy | ||
| Previous Opinion | 96% Sell | 72% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Sell | 8% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.69% since 11/26/24 | +16.59% since 11/26/24 | +20.41% since 11/26/24 | ||
| Low | 4.07 on 11/29/24 | 1.92 on 11/29/24 | 2.48 on 12/02/24 | ||
| High | 4.63 on 12/02/24 | 2.52 on 12/03/24 | 3.63 on 12/04/24 | ||
| 1-Month | |||||
| %Chg | +1.42% since 11/04/24 | +81.06% since 11/04/24 | +36.68% since 11/04/24 | ||
| Low | 4.07 on 11/29/24 | 1.21 on 11/07/24 | 2.21 on 11/19/24 | ||
| High | 4.70 on 11/19/24 | 2.52 on 12/03/24 | 3.63 on 12/04/24 | ||
| 3-Month | |||||
| %Chg | +2.77% since 09/04/24 | +126.54% since 09/04/24 | +83.42% since 09/04/24 | ||
| Low | 3.60 on 09/10/24 | 0.81 on 10/10/24 | 1.60 on 10/10/24 | ||
| High | 5.45 on 09/16/24 | 2.52 on 12/03/24 | 3.63 on 12/04/24 | ||
| 6-Month | |||||
| %Chg | -6.83% since 06/04/24 | +60.40% since 06/04/24 | +26.88% since 06/04/24 | ||
| Low | 3.60 on 09/10/24 | 0.81 on 10/10/24 | 1.60 on 10/10/24 | ||
| High | 5.45 on 09/16/24 | 2.52 on 12/03/24 | 3.63 on 12/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 58,726 | 61,636 | 58,177 | ||
| Shares Outstanding, K | 13,594 | 27,516 | 20,630 | ||
| Annual Sales | 50,160,000 | 0 | 0 | ||
| Annual Net Income | -7,280,000 | -38,370,000 | -40,420,000 | ||
| Last Quarter Sales | 14,060,000 | 0 | 0 | ||
| Last Quarter Net Income | 1,310,000 | -6,090,000 | -11,220,000 | ||
| 60-Month Beta | 0.52 | 2.40 | 1.78 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.09 on 09/11/24 | -0.30 on 11/14/24 | -0.50 on 11/12/24 | ||
| Latest Earnings Date | 12/10/24 | 11/14/24 | 11/15/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||